76 related articles for article (PubMed ID: 22387051)
1. Could age modify the effect of genetic variants in IL6 and TNF-α genes in multiple myeloma?
Martino A; Buda G; Maggini V; Lapi F; Lupia A; Di Bello D; Orciuolo E; Galimberti S; Barale R; Petrini M; Rossi AM
Leuk Res; 2012 May; 36(5):594-7. PubMed ID: 22387051
[TBL] [Abstract][Full Text] [Related]
2. Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone.
Du J; Yuan Z; Zhang C; Fu W; Jiang H; Chen B; Hou J
Leuk Res; 2010 Nov; 34(11):1453-8. PubMed ID: 20122728
[TBL] [Abstract][Full Text] [Related]
3. [Molecular genetic analysis of the interleukin 6 and tumor necrosis factor alpha gene polymorphisms in multiple myeloma].
Iakupova EV; Grinchuk OV; Kalimullina DKh; Bakirov BA; Galimova RR; Makarova OV; Khusnutdinova EK; Viktorova TV
Mol Biol (Mosk); 2003; 37(3):420-4. PubMed ID: 12815949
[TBL] [Abstract][Full Text] [Related]
4. [Effect of TNF-alpha gene polymorphism on outcome of thalidomide-based regimens for multiple myeloma].
DU J; Yuan ZG; Zhang CY; Fu WJ; Jiang H; Chen BA; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2009 Oct; 30(10):649-53. PubMed ID: 19954656
[TBL] [Abstract][Full Text] [Related]
5. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer.
Landi S; Moreno V; Gioia-Patricola L; Guino E; Navarro M; de Oca J; Capella G; Canzian F;
Cancer Res; 2003 Jul; 63(13):3560-6. PubMed ID: 12839942
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of TNF-alpha and LT-alpha genes in multiple myeloma.
Kádár K; Kovács M; Karádi I; Melegh B; Pocsai Z; Mikala G; Tordai A; Szilágyi A; Adány R; Füst G; Várkonyi J
Leuk Res; 2008 Oct; 32(10):1499-504. PubMed ID: 18405969
[TBL] [Abstract][Full Text] [Related]
7. Genetic variability in the severity and outcome of community-acquired pneumonia.
Solé-Violán J; de Castro Fv; García-Laorden MI; Blanquer J; Aspa J; Borderías L; Briones ML; Rajas O; Carrondo IM; Marcos-Ramos JA; Ferrer Agüero JM; Garcia-Saavedra A; Fiuza MD; Caballero-Hidalgo A; Rodriguez-Gallego C
Respir Med; 2010 Mar; 104(3):440-7. PubMed ID: 19900796
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
El-Shabrawi Y; Wegscheider BJ; Weger M; Renner W; Posch U; Ulrich S; Ardjomand N; Hermann J
Ophthalmology; 2006 Apr; 113(4):695-700. PubMed ID: 16581430
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of IL6 promoter and receptor polymorphisms in myelodysplasia and multiple myeloma.
Aladzsity I; Kovács M; Semsei A; Falus A; Szilágyi A; Karádi I; Varga G; Füst G; Várkonyi J
Leuk Res; 2009 Nov; 33(11):1570-3. PubMed ID: 19406470
[TBL] [Abstract][Full Text] [Related]
10. Fatty acids, IL6, and TNFalpha polymorphisms: an example of nutrigenetics in Crohn's disease.
Guerreiro CS; Ferreira P; Tavares L; Santos PM; Neves M; Brito M; Cravo M
Am J Gastroenterol; 2009 Sep; 104(9):2241-9. PubMed ID: 19550417
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.
Cozen W; Gebregziabher M; Conti DV; Van Den Berg DJ; Coetzee GA; Wang SS; Rothman N; Bernstein L; Hartge P; Morhbacher A; Coetzee SG; Salam MT; Wang W; Zadnick J; Ingles SA
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2285-91. PubMed ID: 17119059
[TBL] [Abstract][Full Text] [Related]
13. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of linkage and association of alleles of proinflammatory cytokines genes IL-6, IFNg and TNF with multiple sclerosis using transmission disequilibrium test (TDT)].
Makarycheva OIu; Tsareva EIu; Sudomoina MA; Kulakova OG; Bykova OV; Gol'tsova NV; Kuzenkova LM; Boĭko AN; Favorova OO
Mol Biol (Mosk); 2010; 44(5):824-30. PubMed ID: 21090238
[TBL] [Abstract][Full Text] [Related]
15. Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis.
Shi Q; Wang XS; Li G; Shah ND; Orlowski RZ; Williams LA; Mendoza TR; Cleeland CS
Cancer; 2015 Apr; 121(7):1138-46. PubMed ID: 25469832
[TBL] [Abstract][Full Text] [Related]
16. IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma.
Mazur G; Bogunia-Kubik K; Wróbel T; Karabon L; Polak M; Kuliczkowski K; Lange A
Immunol Lett; 2005 Jan; 96(2):241-6. PubMed ID: 15585329
[TBL] [Abstract][Full Text] [Related]
17. Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura.
Pehlivan M; Okan V; Sever T; Balci SO; Yilmaz M; Babacan T; Pehlıvan S
Platelets; 2011; 22(8):588-95. PubMed ID: 21591983
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in tumor necrosis factor genes and susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high incidence region of North China.
Guo W; Wang N; Li Y; Zhang JH
Chin Med J (Engl); 2005 Nov; 118(22):1870-8. PubMed ID: 16313841
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of interleukin-1 gene complex, IL6 and tumour necrosis factor genes in chronic idiopathic neutropenia of adults.
Addas-Carvalho M; de Paula EV; Lima CS; Saad ST
Ann Hematol; 2005 Oct; 84(11):709-14. PubMed ID: 15986200
[TBL] [Abstract][Full Text] [Related]
20. Association between interleukin-6 polymorphism and age-at-onset of type 1 diabetes. Epistatic influences of the tumor necrosis factor-alpha and interleukin-1beta polymorphisms.
Hermann C; Krikovszky D; Füst G; Kovács M; Körner A; Szabó A; Vannay A; Madácsy L
Eur Cytokine Netw; 2005 Dec; 16(4):277-81. PubMed ID: 16464741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
